The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease
- PMID: 22150547
- PMCID: PMC3319492
- DOI: 10.1111/j.1530-0277.2011.01673.x
The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease
Abstract
Background: Interactions between the gut, immune system, and the liver, as well as the type of fat in the diet, are critical components of alcoholic liver disease (ALD). The goal of the present study was to determine the effects of saturated fat (SF) and unsaturated fat (USF) on ethanol (EtOH)-induced gut-liver interactions in a mouse model of ALD.
Methods: C57BL/6N mice were fed Lieber-DeCarli liquid diets containing EtOH and enriched in USF (corn oil) or SF (medium chain triglycerides:beef tallow). Control mice were pair-fed on an isocaloric basis. Liver injury and steatosis, blood endotoxin levels, intestinal permeability, and tight junction (TJ) integrity, as well as hepatic Toll-like receptor (TLR) gene expression, were evaluated.
Results: After 8 weeks of EtOH feeding, liver injury and steatosis were observed in USF + EtOH group compared with control and SF + EtOH. Significantly increased intestinal permeability in conjunction with elevated blood endotoxin levels were observed in the ileal segments of the mice fed USF + EtOH. USF diet alone resulted in down-regulation of intestinal TJ protein mRNA expression compared with SF. Importantly, alcohol further suppressed TJ proteins in USF + EtOH, but did not affect intestinal TJ in SF + EtOH group. The type of fat in the diet alone did not affect hepatic TLR expression. Compared with control animals, hepatic TLR (TLR 1, 2, 3, 4, 7, 8, 9) mRNA expression was significantly (p < 0.05) increased in USF + EtOH, but not in SF + EtOH group. Notably, TLR5 was the only up-regulated TLR in both SF + EtOH and USF + EtOH groups.
Conclusions: Dietary fat is an important cofactor in alcohol-associated liver injury. We demonstrate that USF (corn oil/linoleic acid) by itself results in dysregulation of intestinal TJ integrity leading to increased gut permeability, and alcohol further exacerbates these alterations. We postulate that elevated blood endotoxin levels in response to USF and alcohol in conjunction with up-regulation of hepatic TLRs combine to cause hepatic injury in ALD.
Copyright © 2011 by the Research Society on Alcoholism.
Figures
Similar articles
-
Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol.Alcohol. 2013 May;47(3):257-64. doi: 10.1016/j.alcohol.2013.01.005. Epub 2013 Feb 26. Alcohol. 2013. PMID: 23453163 Free PMC article.
-
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease.World J Gastroenterol. 2024 Jul 28;30(28):3428-3446. doi: 10.3748/wjg.v30.i28.3428. World J Gastroenterol. 2024. PMID: 39091710 Free PMC article.
-
ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice.Alcohol Clin Exp Res. 2015 Aug;39(8):1465-75. doi: 10.1111/acer.12777. Epub 2015 Jul 14. Alcohol Clin Exp Res. 2015. PMID: 26173414 Free PMC article.
-
Alcoholic Liver Disease: Update on the Role of Dietary Fat.Biomolecules. 2016 Jan 6;6(1):1. doi: 10.3390/biom6010001. Biomolecules. 2016. PMID: 26751488 Free PMC article. Review.
-
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.J Toxicol Sci. 2007 Dec;32(5):453-68. doi: 10.2131/jts.32.453. J Toxicol Sci. 2007. PMID: 18198478 Review.
Cited by
-
Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury.J Nutr Biochem. 2013 Sep;24(9):1609-15. doi: 10.1016/j.jnutbio.2013.02.001. Epub 2013 Apr 22. J Nutr Biochem. 2013. PMID: 23618528 Free PMC article.
-
Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.Am J Physiol Gastrointest Liver Physiol. 2012 Jul;303(1):G32-41. doi: 10.1152/ajpgi.00024.2012. Epub 2012 Apr 26. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22538402 Free PMC article.
-
Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats.Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G919-32. doi: 10.1152/ajpgi.00226.2013. Epub 2013 Oct 10. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 24113767 Free PMC article.
-
Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice.Cell Mol Gastroenterol Hepatol. 2016 May 27;2(5):685-700. doi: 10.1016/j.jcmgh.2016.05.010. eCollection 2016 Sep. Cell Mol Gastroenterol Hepatol. 2016. PMID: 28119953 Free PMC article.
-
Maternal Linoleic Acid Overconsumption Alters Offspring Gut and Adipose Tissue Homeostasis in Young but Not Older Adult Rats.Nutrients. 2020 Nov 11;12(11):3451. doi: 10.3390/nu12113451. Nutrients. 2020. PMID: 33187208 Free PMC article.
References
-
- Amet Y, Adas F, Nanji AA. Fatty acid omega- and (omega-1)-hydroxylation in experimental alcoholic liver disease: relationship to different dietary fatty acids. Alcohol Clin Exp Res. 1998;22:1493–1500. - PubMed
-
- Amin PB, Diebel LN, Liberati DM. Dose-dependent effects of ethanol and E. coli on gut permeability and cytokine production. J Surg Res. 2009;157:187–192. - PubMed
-
- Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther. 1999;291:1075–1085. - PubMed
-
- Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther. 2000;294:997–1008. - PubMed
-
- Bode C, Kolepke R, Schafer K, Bode JC. Breath hydrogen excretion in patients with alcoholic liver disease--evidence of small intestinal bacterial overgrowth. Z Gastroenterol. 1993;31:3–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AA021901/AA/NIAAA NIH HHS/United States
- R01 AA015970-05S2/AA/NIAAA NIH HHS/United States
- R01 AA018869/AA/NIAAA NIH HHS/United States
- R01 AA010762/AA/NIAAA NIH HHS/United States
- R01 AA015970-05/AA/NIAAA NIH HHS/United States
- RC2AA019385/AA/NIAAA NIH HHS/United States
- R01 AA018016-04/AA/NIAAA NIH HHS/United States
- P30 AA019360/AA/NIAAA NIH HHS/United States
- P01 AA017103-02/AA/NIAAA NIH HHS/United States
- R01 AA0015970/AA/NIAAA NIH HHS/United States
- R37 AA010762-10/AA/NIAAA NIH HHS/United States
- R37 AA010762/AA/NIAAA NIH HHS/United States
- P01 AA017103/AA/NIAAA NIH HHS/United States
- RC2 AA019385-01/AA/NIAAA NIH HHS/United States
- R01 AA018016/AA/NIAAA NIH HHS/United States
- R21 AA020849/AA/NIAAA NIH HHS/United States
- R01 DK071765/DK/NIDDK NIH HHS/United States
- RC2 AA019385/AA/NIAAA NIH HHS/United States
- R01 AA010762-05/AA/NIAAA NIH HHS/United States
- R01 AA010496-08/AA/NIAAA NIH HHS/United States
- R01 AA015970/AA/NIAAA NIH HHS/United States
- R01 AA018869-03/AA/NIAAA NIH HHS/United States
- R01 AAO14371/PHS HHS/United States
- R37 AA010762-15/AA/NIAAA NIH HHS/United States
- R01 AA014371/AA/NIAAA NIH HHS/United States
- R01 AA010496/AA/NIAAA NIH HHS/United States
- R01 AA015970-05S1/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources